Plastics for Healthcare Packaging

Report Code: PLS007D

Publish Date: Apr 2010

Publisher: BCC Publishing

Category: Plastics

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The U.S. plastic healthcare packaging market is estimated at 3.8 billion pounds in 2010 and is expected to increase to almost 5 billion pounds by 2015, a 5.6% compound annual growth rate (CAGR).
  • Polypropylene is the largest sector at 987 million pounds in 2010. This sector is projected to increase at a compound annual growth rate (CAGR) of 6.3% to 1.3 billion pounds in 2015.
  • The PVC market is estimated at 845 million pounds in 2010. By 2015, this sector will reach 1 billion pounds, a compound annual growth rate (CAGR) of 5%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
This study looks in detail at the use of plastics in the packaging of healthcare products segmented by pharmaceutical and medical packaging.
  • Pharmaceutical products, which are defined as drugs in dosage forms that are purchased and consumed by individual patients, and are either prescribed by a licensed medical practitioner or are drugs that do not require a prescription and are purchased by individuals “over the counter” (OTC). These products are usually packaged in containers, blister packs, bags/pouches, etc.
  • Medical products, i.e., those used by medical practitioners themselves, in hospitals, clinics, home healthcare operations, etc. Examples are syringes, blood and intravenous solution bags, diagnostic kits, tubing, trays and other similar items. 
The focus of this study is on plastics that are used in packaging of healthcare products and their various plastic healthcare packaging products. The objective of this report is to discuss, analyze, and forecast markets for the use of major plastics used in packaging important healthcare products.
  
REASONS FOR DOING THE STUDY
 
The objective of this study is to provide a comprehensive reference for those interested and/or involved in the use of plastics for packaging healthcare products. This is a wide and varied group of those in the pharmaceutical, medical and plastics industries.
 
Healthcare plastics find increased use each year in applications in healthcare packaging. In these changing times, with emphasis on healthcare cost control, plastics are increasing their penetration in packaging. This study covers these changes and provides analyses and forecasts for use of different plastics in this packaging market.
  
INTENDED AUDIENCE
 
This report is intended to assist those involved in plastics, packaging, and healthcare products. These organizations and people include those involved in development, formulation, manufacture, sale, and use of plastics in healthcare packaging
 
Since a significant market for the use of plastics is the prime focus of this study, it will be of interest and value to those involved in polymer and polymer processes, from manufacture of bulk resins to converting and other plastics fabrication processes. It will also be of major interest to those who use plastics in packaging healthcare products, both healthcare end-user companies and contract packagers, along with plastics producers. 
 
Companies and personnel in ancillary businesses such as processing equipment, additives, and other support chemicals and equipment will find information useful to their operations. These include process and product development staff, process and product designers, purchasing agents, construction and operating personnel, market staff, and top management. This report can be of great value to technical and business personnel in the following areas, among others: 
  • Marketing and management personnel in companies that produce, market, and sell all types of plastics, i.e., virgin, specially compounded, and recycled.
  • Companies that supply or want to supply equipment and services to plastics processors.
  • Financial institutions that provide funding for such facilities, including banks, merchant bankers, venture capitalists, and others.
  • Personnel in end-user companies and industries that purchase and use packaging plastics ranging from converters, compounders, and molders to contract packaging companies and healthcare company end-users. Healthcare packagers are a key group of companies who could be interested, as well.
  • Personnel in government at many levels. This includes federal officials, primarily at the EPA and FDA, who are involved with protection of national standards regarding public health and safety. 
SCOPE OF REPORT
 
This study covers many of the most important economic, technological, regulatory, and environmental considerations in U.S. markets for the use of plastics to package healthcare products.
 
It is primarily a study of activities and markets in the United States, but because of the global nature of polymer and packaging chemistry in both the plastics and healthcare industries, it touches on some noteworthy international activities.
 
These are primarily those which can have an impact on U.S. activities and markets, such as activities of foreign-based companies in U.S. markets, and international technologies, standards and protocols. 
 
The market volumes in this report refer to the U.S., although there are often significant amounts of finished products made or shipped offshore. There is usually less of an impact regarding offshore sourcing in healthcare-related markets than in most others primarily because of the nature of the industry: product failures obviously have more a more critical effect on users.
 
All market volume figures are rounded to the nearest million or billion pounds. Growth rates are all compounded (signified as compounded average annual growth rates or CAGRs). Due to this rounding, some growth rates may not agree exactly with figures in the market tables.
 
Some topics and materials covered in the text of this report are not included in the market forecast tables simply because either volumes are too low to broadly estimate or volumes may be proprietary.
 
There are also a wide variety of terms used almost interchangeably, which often makes it difficult to specifically segment several products used in healthcare packaging because, in many cases, they are multifunctional such as: 
  • Trays vs. kits
  • Pouches vs. bags
  • Closures vs. caps
  • Containers vs. bottles
  • Closures vs. lidding
A final point is that there are often times when there is a need to review some preliminary but important background details in the detailed pharmaceutical and medical sections for those readers who purchase certain sections of the report rather than the complete report
  
METHODOLOGY AND INFORMATION SOURCES
 
Searches were made of the literature, including many of the leading trade publications, and well as technical compendia, government publications, and information from trade and other associations. Product and market information was obtained whenever possible from the principals involved. The information for the company profiles was obtained primarily from company literature. Other sources included directories and articles.
  
ABOUT THE AUTHOR
 
Research analyst Mel Schlechter has more than 40 years in the chemical industry and specializes in plastics market research. He has been with BCC Research for more than a decade and holds a B.S. in chemistry, M.S. in organic chemistry, and a M.B.A. in marketing. 
  
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at
www.bccresearch.com enables readers to: 
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers. 
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Plastics for Healthcare Packaging222Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: HEALTHCARE INDUSTRY OVERVIEW17Free
Chapter- 4: HEALTHCARE PACKAGING30Free
Chapter- 5: HEALTHCARE PACKAGING PLASTIC PROCESSES6Free
Chapter- 6: HEALTHCARE PACKAGING MARKET BY RESIN60Free
Chapter- 7: HEALTHCARE PACKAGING MARKETS BY APPLICATION56Free
Chapter- 8: STERILIZATION TECHNIQUES5Free
Chapter- 9: IMPORTANT AREAS AFFECTING THE HEALTHCARE7Free
Chapter- 10: OTHER IMPORTANT ASPECTS OF THE HEALTHCARE PACKAGING BUSINESS5Free
Chapter- 11: ENVIRONMENTAL ISSUES6Free
Chapter- 12: FEDERAL LAWS AND REGULATORY PROCESSES3Free
Chapter- 13: RECENT HEALTHCARE PACKAGING COMPANY DEVELOPMENTS3Free
Chapter- 14: C. CRAMER & CO. GMBH18Free
Published - Feb-2005| Analyst - Melvin Schlechter| Code - PLS007C

Report Highlights

  • The plastic healthcare packaging market in North America is estimated at 2.5 billion pounds for 2004 and is expected to increase to slightly more than 3.2 billion pounds by 2009, at an average annual growth rate (AAGR) of 5%.
  • Polypropylene represents nearly 28% of the market and will rise at an AAGR of 5.1% to 913 million pounds in 2009.
  • PVC is, and will remain with the second highest share despite efforts to reduce its use. PVC still is regarded as a cost-effective and safe material by the industry.
  • Bottles/vials, tubing/containers, syringes and kits are estimated to be the leading healthcare packaging applications, accounting for more than 83% of total plastic volume in 2004.

Related Reports

Recent Reports

Global Markets for Plastics Additives

Published - Nov 2024 | Publisher - BCC Publishing | Code - PLS022H

The global market for plastics additives reached $58.9 billion in 2023. The market is expected to grow from $61.5 billion in 2024 to $80.7 billion by 2029, at a compound annual growth rate (CAGR) of 5.6% from 2024 through 2029.

Sustainable Packaging: Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - PLS121B

The global market for sustainable packaging is estimated to increase from $278.1 billion in 2023 to reach $391.1 billion by 2029, at a compound annual growth rate (CAGR) of 6.0% from 2024 through 2029.

Sustainable Plastic Packaging: Global Markets

Published - Aug 2024 | Publisher - Noopur Deshmukh | Code - PLS122B

The global market for sustainable plastic packaging was valued at $81.6 billion in 2023. The market is expected to grow from $86.6 billion in 2024 to $122.4 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 7.2% from 2024 to 2029.

Recycled Plastics in Construction Market

Published - Jul 2024 | Publisher - Yukti Chaturvedi | Code - PLS125A

This report offers a qualitative as well as quantitative analysis of recycled plastics in the construction market. The quantitative analysis includes market estimates and forecasts and is applicable only to buildings. However, it includes trends pertaining to the global construction sector.

Plastic Injection Molding: Global Markets and Technologies

Published - Jul 2024 | Publisher - Yukti Chaturvedi | Code - PLS089D

The global market for plastic injection molding was valued at $191.0 billion in 2023. The market is estimated to grow from $192.7 billion in 2024 to $235.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Plastics for Healthcare Packaging
Customize Report